Advertisement

Topics

Eligard - Biotech, Pharma and Life Science Channel

22:10 EDT 25th April 2017 | BioPortfolio

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormone testosterone, thus suppressing testosterone-dependent tumor growth. The established active ingredient is combined with a novel drug delivery system known as Atrigel® depot technology. The liquid drug is injected subcutaneously and Eligard® forms a gel-like implant which slowly disintegrates, steadily releasing the drug over a period of one, three or six months, depending on the dosage administered.

Medigene acquired the European marketing rights to Eligard® from Atrix Laboratories, Inc. (now Tolmar Therapeutics, Inc.) and successfully brought the drug through the market approval procedure in Germany. The European market launch of Eligard® by Medigene’s partner Astellas Pharma Europe, Ltd. started as early as 2004. Eligard® in its one-month, three-month and six-month dosage forms is now available in most European countries.

In mid-2010, Medigene sold the exclusive European marketing and distribution rights for Eligard® to Astellas Pharma Europe Ltd. against payment of €25 million and royalties of 2% on product sales. With the sale of the Eligard® rights, Medigene no longer bears any obligations or risks associated with the supply of Eligard® to Astellas. In addition, Medigene will no longer be liable for any procurement costs and license payments to Tolmar.

In June 2012, Medigene transferred its two percent royalty share of Eligard® European net sales to US-based investor, Cowen Healthcare Royalty Partners II, L.P., for a cash payment of appr. €14.1 million. Medigene plans to invest these proceeds in further strengthening the company’s pipeline.

Source: http://www.medigene.com/products-pipeline/products/eligard

News Articles [81 Associated News Articles listed on BioPortfolio]

TECFIDERA® and TYSABRI® Data Demonstrate Improved Outcomes with Early MS Treatment

Real-world Data Further Confirm Strong Efficacy of TECFIDERA in Newly Diagnosed and Early Switch Patients MS Patients with High Disease Activity Benefit from Early and ...

Sunovion to Present Data on Aptiom® (eslicarbazepine acetate) at the American Academy of Neurology 2017 Annual Meeting

– Presentations include efficacy, safety and quality of life data from monotherapy and adjunctive therapy trials in adults with partial-onset seizures (POS) – ...

Foresee Pharmaceuticals Announces Key Executive Appointments

TAIPEI, Taiwan, April 13, 2017 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today the appointment of two key executives with strong medical, scientific and drug ...

TOLMAR Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 24022017] Prices from USD $250

SummaryTOLMAR Inc TOLMAR, a subsidiary of Tolmar Holding Inc, develops, manufactures and markets leuprolide acetates, dermatology and other products. It offers dermatology products such as lidocaine a...

AbbVie Announces Positive Phase 2b Data Demonstrating Investigational Medicine Elagolix Significantly Reduced Heavy Menstrual Bleeding in Women with Uterine Fibroids

NORTH CHICAGO, Ill., April 7, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced detaile...

Global Vinyl Acetate Market 20172021 [Updated: 07032017] Prices from USD $3500

ABSTRACTAbout Vinyl AcetateVinyl acetate is an organic compound, which is commonly used for the production of polyvinyl alcohol PVOH, polyvinyl acetate PVA, ethylene vinyl acetate EVA, and ethylene vi...

Foresee Pharmaceuticals Announces Completion of USD16M Fundraising

TAIPEI, Taiwan, April 5, 2017 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today the completion of a USD16 Million (NTD496M) financing in issuance of 8 million c...

Enteris BioPharma to Present at the 24th Annual Future Leaders in the Biotech Industry Conference

BOONTON, N.J., March 30, 2017 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, today announced t...

Enteris BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 23032017] Prices from USD $250

SummaryEnteris BioPharma Inc Enteris is a biotechnology company which offers formulation solutions based on proprietary delivery technologies. Its lead product candidate, Ovarest oral leuprolide, an o...

Astellas Pharma Inc 4503 Medical Equipment Deals and Alliances Profile [Updated: 14022017] Prices from USD $250

SummaryAstellas Pharma Inc Astellas is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceutic...

Events [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Sunovion Pharmaceuticals, Inc.

Sunovion is a leading pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the Psychiatry &...

Celanese Corporation

We are an integrated global producer of value-added industrial chemicals and have the first or second market positions worldwide in products comprising the majority of our sales. We are the world’s ...

Graceway Pharmaceuticals, LLC

Graceway Pharmaceuticals, LLC ("Graceway"), headquartered in Bristol, TN, is a pharmaceutical company focused on acquiring, in-licensing, and developing branded prescription pharm...

Proof Eyewear

Proof was established in 2010 by three brothers in Boise, Idaho. They were inspired by their entrepreneur grandfather who started a wood sawmill and also by the outdoors around th...

Clinical Trials [580 Associated Clinical Trials listed on BioPortfolio]

Lotoprednol vs. Prednisolone and Fluorometholone

Corneal haze, in which the cornea becomes cloudy, is a well-known and a potentially vision-threatening postoperative complication of PRK. Topical ophthalmic corticosteroids are routinely p...

Bioequivalence of Two Different Sources of Eslicarbazepine Acetate

The purpose of this study is to determine whether the test product, eslicarbazepine acetate 800 mg tablets (test 1, To be marketed (TBM) Treatment A), and the reference product, eslicarbaz...

A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

A study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset Seizures

A Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

A drug study to determine the long-term safety and tolerability in children and adolescents (4-17 years in age) taking the drug (elsicarbazepine acetate)

Ovulation Incidence in Oral Contraceptive Users

Since the introduction of the combined hormonal contraceptive pill, dosages of ethinyl estradiol (EE) have steadily decreased from more than 150mcg to 20mcg in an attempt to improve the ri...

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

The purpose of this study is to determine the benefit and safety of relugolix 40 mg once daily co-administered with low dose estradiol and norethindrone acetate compared with placebo for 2...

A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer

This research study is studying a combination of drugs as a possible treatment for castration-resistant prostate cancer. The interventions involved in this study are: - Docetaxe...

Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial

Efficacy and safety of OctaplasLG® administration vs. crystalloids (standard) in patients with septic shock - a randomized, controlled, open-label investigator-initiated pilot trial

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Hormonal evaluation of women who are suspected of having Polycystic ovary syndrome (PCOS) involves the measurement of basal levels of androgens and 17-hydroxyprogesterone (17-OHP), which a...

A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

The purpose of this study is to determine the benefit and safety of relugolix 120 mg once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (

PubMed Articles [690 Associated PubMed Articles listed on BioPortfolio]

Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles.

Dexamethasone acetate (DA) produces neuroprotective effects by inhibiting lipid peroxidation and inflammation by reducing cytokine release and expression. However, its clinical application is limited ...

Protein separation through preliminary experiments concerning pH and salt concentration by tube radial distribution chromatography based on phase separation multiphase flow using a polytetrafluoroethylene capillary tube.

Protein mixtures were separated using tube radial distribution chromatography (TRDC) in a polytetrafluoroethylene (PTFE) capillary (internal diameter=100µm) separation tube. Separation by TRDC is bas...

Characterization and application of cellulose acetate synthesized from sugarcane bagasse.

The synthesis and application of cellulose acetate (CA) from sugarcane bagasse were investigated. Firstly, cellulose was extracted by a sequential treatment with H2SO4 (10% v/v), NaOH (5% w/v), EDTA (...

Tocopheryl acetate release from microcapsules of waxy maize starch.

Diffusion coefficients are utilised to provide a realistic approach in the quantification of mass transport phenomena, which are important for the delivery of bioactivity from high-solid biopolymer sy...

A study of CO/syngas bioconversion by Clostridium autoethanogenum with a flexible gas-cultivation system.

Bioconversion of CO/syngas to produce ethanol is a novel route in bioethanol production, which can be accomplished by some acetogens. Specific culture vessels and techniques are needed to cultivate th...

Suppression of Oral Sweet Taste Sensation with Gymnema sylvestre Affects Postprandial Gastrointestinal Blood Flow and Gastric Emptying in Humans.

An oral sweet taste sensation (OSTS) exaggerates digestive activation transiently, but whether it has a role after swallowing a meal is not known. Gymnema sylvestre (GS) can inhibit the OSTS in humans...

Facile green synthesis of silver nanodendrite/cellulose acetate thin film electrodes for flexible supercapacitors.

In this study, we present a highly efficient and economical solution called as 'in situ hydrogenation' for preparation of highly conductive thin film electrode based on silver nanodendrites. The silve...

Starch materials as biocompatible supports and procedure for fast separation of macrophages.

Different starch derivatives were evaluated as supports for attachment and recovery of macrophages (RAW 264.7 line). Gelatinized starch (G-St), acetate starch (Ac-St), carboxymethyl starch and aminoet...

Enhanced antibacterial metabolite production through the application of statistical methodologies by a Streptomyces nogalater NIIST A30 isolated from Western Ghats forest soil.

Streptomyces strains isolated from Nelliyampathy forest soil of Western Ghats, Kerala, India were evaluated for their antibacterial efficacy against two indicator pathogenic bacteria (Escherichia coli...

Effect of feeding two RRR-alpha-tocopherol formulations on serum, cerebrospinal fluid and muscle alpha-tocopherol concentrations in horses with subclinical vitamin E deficiency.

Alpha tocopherol (α-TP) supplementation is recommended for the prevention of various equine neuromuscular disorders. Formulations available include RRR-α-TP acetate powder and a more expensive but r...

Videos

None available.

Medical and Biotech [MESH] Definitions

An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6.

Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.

An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1.

An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.

Quick Search
Advertisement
 

Relevant Topics

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

review and buy Eligard market research data and corporate reports here

Channels Quicklinks